首页|肺泡灌洗联合孟鲁司特钠治疗AECOPD的疗效及对患者氧化应激、炎症因子的影响

肺泡灌洗联合孟鲁司特钠治疗AECOPD的疗效及对患者氧化应激、炎症因子的影响

Efficacy of alveolar lavage combined with montelukast in the treatment of acute exacerbations of chronic obstructive pulmonary disease and its effect on oxidative stress and inflammatory factors in patients

扫码查看
目的 探讨肺泡灌洗联合孟鲁司特钠治疗慢阻肺急性加重期(AECOPD)的疗效及对患者氧化应激、炎症因子的影响.方法 选择单县中心医院重症医学科2021年12月至2022年12月收治的AECOPD患者90例进行前瞻性研究,采用随机数字表法分为对照组与观察组各45例,对照组予以常规治疗,观察组加用肺泡灌洗联合孟鲁司特钠治疗.比较两组治疗前后症状评分、急性生理与慢性健康评分Ⅱ(APACHE Ⅱ)评分以及有效率、氧化应激[丙二醛(MDA)、4-羟基壬烯醛(4-HNE)及超氧化物歧化酶(SOD)水平]、炎症因子指标[C反应蛋白(CRP)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、降钙素原(PCT)].结果 治疗后,两组症状评分均显著下降(t=6.68、11.32,P<0.05),观察组显著低于对照组[(8.69±0.84)分比(15.39±1.18)分,t=8.75,P<0.05];治疗后观察组APACHE Ⅱ评分显著低于对照组(t=9.19,P<0.05);观察组总有效率[93.33%(42/45)]显著高于对照组[75.56%(34/45)](t=4.56,P<0.05);治疗后,观察组血清4-HNE及MDA均显著低于对照组(t=4.20、5.15,均P<0.05),SOD显著高于对照组(t=5.23,P<0.05);治疗后,观察组CRP、TNF-α、IL-6、PCT水平均显著低于对照组(t=6.86、5.60、8.75、4.89,均P<0.05).结论 肺泡灌洗联合孟鲁司特钠能够减轻AECOPD患者临床症状,促进疾病恢复,提高临床疗效,降低患者氧化应激反应,增加机体抗氧能力,减少炎症因子表达,减轻患者的炎症反应.
Objective To investigate the efficacy of alveolar lavage combined with montelukast in the treatment of acute exacerbations of chronic obstructive pulmonary disease(AECOPD)and its effect on oxidative stress and inflammatory factors in patients.Methods A prospective study was conducted involving 90 patients with AECOPD who were admitted to the Intensive Care Unit of Shan County Central Hospital from December 2021 to December 2022.The patients were randomly divided into a control group and an observation group,with 45 patients in each group,using the random number table method.The control group received conventional treatment,while the observation group was additionally treated with alveolar lavage combined with montelukast.Symptom score,Acute Physiology and Chronic Health Evaluation Ⅱ score,overall response rate,serum levels of oxidative stress markers(malondialdehyde,4-hydroxynonenal,and superoxide dismutase),and serum levels of inflammatory factors(C-reactive protein,tumor necrosis factor-α,interleukin-6,and procalcitonin)were compared between the two groups before and after treatment.Results After treatment,the symptom scores for both groups decreased significantly compared with their respective scores before treatment(t=6.68,11.32,both P<0.05).After treatment,the symptom score in the observation group was significantly lower than that in the control group[(8.69±0.84)points vs.(15.39±1.18)points,t=8.75,P<0.05].After treatment,the Acute Physiology and Chronic Health Evaluation Ⅱ score in the observation group was significantly lower than that in the control group(t=9.19,P<0.05).The overall response rate in the observation group was significantly higher than that in the control group[93.33%(42/45)vs.75.56%(34/45),t=4.56,P<0.05].After treatment,serum levels of 4-hydroxynonenal and malondialdehyde in the observation group were significantly lower than those in the control group(t=4.20,5.15,both P<0.05),while serum level of superoxide dismutase in the observation group was significantly higher than that in the control group(t=5.23,P<0.05).After treatment,serum levels of C-reactive protein,tumor necrosis factor-α,interleukin-6,and procalcitonin in the observation group were significantly lower than those in the control group(t=6.86,5.60,8.75,4.89,all P<0.05).Conclusion Alveolar lavage combined with montelukast can reduce clinical symptoms in patients with AECOPD,promote recovery,enhances clinical efficacy,decreases oxidative stress responses,increases the body's antioxidant capacity,lowers the expression of inflammatory factors,and reduces inflammatory responses.

Bronchoalveolar lavagePulmonary disease,chronic obstructiveOxidative stressC-reactive proteinTreatment outcome

张贵真、陈爽、刘景刚、张珂、孟亚、王娜、高亚平

展开 >

单县中心医院重症医学科,菏泽 274300

单县中心医院呼吸危重症,菏泽 274300

单县中心医院急诊科,菏泽 274300

支气管肺泡灌洗 肺疾病,慢性阻塞性 氧化性应激 C反应蛋白质 治疗结果

2024

中国基层医药
中华医学会,安徽医科大学

中国基层医药

影响因子:1.003
ISSN:1008-6706
年,卷(期):2024.31(9)
  • 17